Literature DB >> 15358631

The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression.

Andrea Caporali1, Pierpaola Davalli, Serenella Astancolle, Domenico D'Arca, Maurizio Brausi, Saverio Bettuzzi, Arnaldo Corti.   

Abstract

Clusterin (CLU) protein is widely distributed in animal tissues and is involved in many different processes, including apoptosis and neoplastic transformation. Green tea catechins (GTC) are known to exert chemopreventive effects in many cancer models, including transgenic adenocarcinoma mouse prostate (TRAMP) mice that spontaneously develop prostate cancer (CaP). We report here that growth of SV40-immortalized human prostate epithelial cells (PNT1A) as well as tumorigenic, poorly differentiated prostate cancer cells (PC-3) was potently inhibited by EGCG, the major green tea catechin, while normal human prostate epithelial cells were not significantly affected. IC(50) doses of EGCG for 24 h caused caspase cascade activation and CLU protein accumulation in both cells lines but not in normal cells, in which CLU remained undetectable. While 100% of TRAMP mice developed CaP, only 20% of those receiving 0.3% GTC in drinking water developed the neoplasm. In TRAMP mice, the CLU gene was dramatically down-regulated during onset and progression of CaP. In GTC-treated TRAMP mice in which tumor progression was chemoprevented, CLU mRNA and protein progressively accumulated in the prostate gland. CLU dropped again to undetectable levels in animals in which GTC chemoprevention failed and CaP developed. Up-regulation of histone H3 and down-regulation of growth arrest-specific gene 1 (Gas1) mRNAs in CaP-developing TRAMP mice demonstrated a high proliferation rate in tumors, while the opposite occurred in the glands of GTC chemoprevented animals. Failure of GTC chemoprevention caused induction of both histone H3 and Gas1 and down-regulation of CLU. Immunohistochemistry experiments confirmed CLU down-regulation during CaP onset and progression, and CLU sustained expression in chemoprevented TRAMP mice. A possible role for CLU as a novel tumor-suppressor gene in the prostate is thus suggested.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358631     DOI: 10.1093/carcin/bgh235

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  41 in total

Review 1.  The strategies to control prostate cancer by chemoprevention approaches.

Authors:  Harold Ting; Gagan Deep; Chapla Agarwal; Rajesh Agarwal
Journal:  Mutat Res       Date:  2014-01-02       Impact factor: 2.433

Review 2.  Regulation of CLU gene expression by oncogenes and epigenetic factors implications for tumorigenesis.

Authors:  Arturo Sala; Saverio Bettuzzi; Sabina Pucci; Olesya Chayka; Michael Dews; Andrei Thomas-Tikhonenko
Journal:  Adv Cancer Res       Date:  2009       Impact factor: 6.242

3.  The association of tea consumption and the risk and progression of prostate cancer: a meta-analysis.

Authors:  Xiawei Fei; Yanting Shen; Xiaogong Li; Hongqian Guo
Journal:  Int J Clin Exp Med       Date:  2014-11-15

Review 4.  Dietary factors and epigenetic regulation for prostate cancer prevention.

Authors:  Emily Ho; Laura M Beaver; David E Williams; Roderick H Dashwood
Journal:  Adv Nutr       Date:  2011-11-03       Impact factor: 8.701

5.  Safety and chemopreventive effect of Polyphenon E in preventing early and metastatic progression of prostate cancer in TRAMP mice.

Authors:  Seung Joon Kim; Ernest Amankwah; Shahnjayla Connors; Hyun Y Park; Maria Rincon; Heather Cornnell; Ganna Chornokur; Arig Ibrahim Hashim; Junsung Choi; Ya-Yu Tsai; Robert W Engelman; Nagi Kumar; Jong Y Park
Journal:  Cancer Prev Res (Phila)       Date:  2014-02-05

6.  Clusterin and FOXL2 act concordantly to regulate pituitary gonadotroph adenoma growth.

Authors:  Vera Chesnokova; Svetlana Zonis; Kolja Wawrowsky; Yuji Tani; Anat Ben-Shlomo; Vladimir Ljubimov; Adam Mamelak; Serguei Bannykh; Shlomo Melmed
Journal:  Mol Endocrinol       Date:  2012-10-09

Review 7.  Green tea polyphenols for prostate cancer chemoprevention: a translational perspective.

Authors:  J J Johnson; H H Bailey; H Mukhtar
Journal:  Phytomedicine       Date:  2010-01       Impact factor: 5.340

8.  Lack of evidence for green tea polyphenols as DNA methylation inhibitors in murine prostate.

Authors:  Shannon R Morey Kinney; Wa Zhang; Marien Pascual; John M Greally; Bryan M Gillard; Ellen Karasik; Barbara A Foster; Adam R Karpf
Journal:  Cancer Prev Res (Phila)       Date:  2009-11-24

9.  Effective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on the stage of the disease.

Authors:  Vaqar Mustafa Adhami; Imtiaz Ahmad Siddiqui; Sami Sarfaraz; Sabih Islam Khwaja; Bilal Bin Hafeez; Nihal Ahmad; Hasan Mukhtar
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

Review 10.  Apoptosis by dietary agents for prevention and treatment of prostate cancer.

Authors:  Naghma Khan; Vaqar Mustafa Adhami; Hasan Mukhtar
Journal:  Endocr Relat Cancer       Date:  2010-01-29       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.